| 3.8 |
11.2 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 3.6 |
10.8 |
GO:0038095 |
positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
| 3.2 |
19.3 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 3.0 |
12.1 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 2.8 |
14.1 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 2.8 |
8.3 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 2.6 |
7.9 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 2.1 |
6.2 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 2.0 |
8.1 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 2.0 |
6.0 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 2.0 |
9.8 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 1.9 |
13.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.8 |
3.7 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 1.8 |
9.0 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 1.8 |
5.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 1.7 |
5.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.5 |
15.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 1.5 |
4.4 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 1.4 |
2.7 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 1.4 |
4.1 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.3 |
6.6 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.3 |
5.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 1.3 |
3.8 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 1.3 |
7.6 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 1.2 |
3.7 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 1.2 |
8.1 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 1.1 |
12.5 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 1.1 |
2.3 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 1.1 |
4.5 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.1 |
3.3 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 1.1 |
6.7 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 1.1 |
3.3 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 1.1 |
5.4 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 1.0 |
3.1 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.0 |
3.0 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 1.0 |
5.9 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.9 |
3.8 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.9 |
1.9 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.9 |
2.8 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.9 |
2.7 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.9 |
3.5 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.9 |
3.4 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.8 |
2.5 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.8 |
4.2 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.8 |
5.9 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.8 |
4.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.8 |
2.3 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.7 |
5.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.7 |
2.2 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.7 |
0.7 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.7 |
2.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.7 |
10.5 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.7 |
4.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.7 |
2.0 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.7 |
3.3 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.6 |
3.2 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.6 |
1.3 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.6 |
2.5 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.6 |
1.9 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.6 |
3.1 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.6 |
1.9 |
GO:1905050 |
positive regulation of metalloendopeptidase activity(GO:1904685) positive regulation of metallopeptidase activity(GO:1905050) |
| 0.6 |
2.5 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.6 |
1.9 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.6 |
1.2 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.6 |
5.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.6 |
1.7 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.6 |
0.6 |
GO:0048389 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) ureter urothelium development(GO:0072190) kidney smooth muscle tissue development(GO:0072194) |
| 0.6 |
4.4 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.5 |
2.2 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.5 |
7.0 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.5 |
3.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.5 |
2.0 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.5 |
10.1 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.5 |
1.5 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.5 |
2.5 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.5 |
8.4 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.5 |
5.9 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.5 |
2.9 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.5 |
1.0 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.5 |
2.4 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.5 |
1.9 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.5 |
2.9 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.5 |
8.0 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.5 |
2.3 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.5 |
2.8 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.5 |
1.4 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.5 |
1.8 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.4 |
1.3 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.4 |
2.2 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.4 |
3.0 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.4 |
1.3 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.4 |
5.0 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.4 |
6.3 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.4 |
1.2 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.4 |
0.4 |
GO:0048625 |
norepinephrine biosynthetic process(GO:0042421) myoblast fate commitment(GO:0048625) |
| 0.4 |
1.2 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.4 |
3.6 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.4 |
6.0 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.4 |
1.6 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.4 |
0.8 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.4 |
0.4 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.4 |
1.2 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.4 |
1.5 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.4 |
0.4 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.4 |
8.2 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.4 |
3.3 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 |
2.9 |
GO:2000192 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of fatty acid transport(GO:2000192) |
| 0.4 |
1.5 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
| 0.4 |
1.8 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.4 |
2.1 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.3 |
5.9 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.3 |
2.4 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.3 |
1.0 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 |
3.9 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
3.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.3 |
1.0 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.3 |
3.9 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.3 |
1.0 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.3 |
1.0 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.3 |
0.9 |
GO:0086069 |
desmosome assembly(GO:0002159) bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.3 |
8.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.3 |
0.9 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.3 |
1.2 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 |
0.9 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.3 |
2.3 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.3 |
0.9 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 |
1.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
3.6 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.3 |
1.4 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.3 |
2.4 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.3 |
0.8 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) endothelial cell-cell adhesion(GO:0071603) |
| 0.3 |
2.7 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.3 |
3.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.3 |
0.8 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.3 |
1.8 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 |
1.8 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.3 |
0.8 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.3 |
2.0 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.3 |
2.3 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 |
0.7 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.2 |
0.7 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 |
1.2 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.2 |
1.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 |
0.7 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.2 |
0.7 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.2 |
4.1 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.2 |
7.6 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.2 |
1.1 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 |
1.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.2 |
2.0 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 |
0.7 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.2 |
37.2 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.2 |
2.1 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 |
1.5 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 |
0.4 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
2.9 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.2 |
0.4 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.2 |
0.6 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.2 |
2.5 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.2 |
0.6 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 |
0.4 |
GO:0032740 |
positive regulation of interleukin-17 production(GO:0032740) |
| 0.2 |
2.0 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 |
3.0 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.8 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 |
0.8 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
0.8 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.2 |
0.6 |
GO:1903525 |
regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) regulation of membrane tubulation(GO:1903525) |
| 0.2 |
0.8 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.2 |
0.4 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 |
1.4 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
0.8 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 |
2.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
12.4 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
1.1 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 |
0.7 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 |
7.0 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.2 |
1.2 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.2 |
2.8 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 |
4.3 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
1.0 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.2 |
1.5 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.2 |
2.0 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 |
2.3 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.2 |
2.7 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.2 |
0.3 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.2 |
3.1 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.2 |
9.6 |
GO:0051017 |
actin filament bundle assembly(GO:0051017) |
| 0.2 |
0.5 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 0.2 |
5.1 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.2 |
0.5 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.2 |
0.5 |
GO:1903546 |
receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 |
0.5 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.2 |
9.0 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 |
0.8 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.2 |
0.3 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.2 |
0.8 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.2 |
7.7 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
0.2 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.2 |
0.6 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
3.3 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.2 |
0.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
1.7 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.2 |
2.7 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.2 |
2.0 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
1.5 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.2 |
1.4 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 |
0.3 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 |
1.8 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 |
1.2 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
1.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
1.0 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
2.8 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
1.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
1.1 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 |
1.0 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.6 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.7 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.4 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.1 |
3.5 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
2.0 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
0.7 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.9 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.1 |
0.1 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 |
1.4 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.1 |
0.7 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.2 |
GO:0045346 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.1 |
0.7 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.9 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
1.3 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.7 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
1.6 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
0.4 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
1.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
0.6 |
GO:0043314 |
negative regulation of cellular extravasation(GO:0002692) negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.1 |
1.8 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.1 |
1.4 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 |
0.4 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 |
1.4 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
1.6 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 |
1.4 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.1 |
0.8 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
0.2 |
GO:0014042 |
positive regulation of neuron maturation(GO:0014042) |
| 0.1 |
1.7 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.1 |
1.6 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.2 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.1 |
1.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.6 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
1.4 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 |
1.0 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.1 |
0.4 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
1.3 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 |
4.0 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
0.9 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
1.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.6 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.4 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
2.0 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 |
0.5 |
GO:0071384 |
cellular response to corticosteroid stimulus(GO:0071384) |
| 0.1 |
0.6 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.2 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) regulation of acrosome reaction(GO:0060046) |
| 0.1 |
0.9 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.1 |
2.6 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
2.2 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
1.4 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.1 |
0.8 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
1.9 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
0.8 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
0.4 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
1.8 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.3 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.3 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.3 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
2.8 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.2 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.1 |
1.1 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.1 |
3.3 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.1 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.1 |
0.4 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
1.3 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.5 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
0.3 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.4 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.9 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.1 |
0.5 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.5 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.4 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 |
0.6 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 |
3.9 |
GO:0007613 |
memory(GO:0007613) |
| 0.1 |
0.4 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.1 |
0.7 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
1.1 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
3.1 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.1 |
1.3 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.7 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.1 |
1.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 |
0.4 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
3.4 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
1.4 |
GO:0010506 |
regulation of autophagy(GO:0010506) |
| 0.0 |
0.3 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
0.6 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
1.1 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
3.8 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.0 |
0.6 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
1.2 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 |
0.2 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
2.4 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.0 |
0.4 |
GO:0044065 |
regulation of respiratory system process(GO:0044065) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.8 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
1.1 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.2 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.9 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.5 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
0.9 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.4 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
1.1 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.0 |
1.3 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.5 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.6 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.3 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
2.6 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
0.7 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.1 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.9 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.4 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.3 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.0 |
0.6 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
1.4 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.3 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.0 |
0.2 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
1.9 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
1.0 |
GO:0045834 |
positive regulation of lipid metabolic process(GO:0045834) |
| 0.0 |
0.2 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.5 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.0 |
0.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.0 |
0.2 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
1.4 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
| 0.0 |
0.6 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) fat pad development(GO:0060613) |
| 0.0 |
0.2 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 |
0.1 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.3 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.3 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.9 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.0 |
1.5 |
GO:0070085 |
glycosylation(GO:0070085) |
| 0.0 |
0.3 |
GO:0006814 |
sodium ion transport(GO:0006814) |
| 0.0 |
0.3 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.1 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.3 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
